LGT Financial Advisors »

Terns Pharmaceuticals shares owned by LGT Financial Advisors

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by LGT Financial Advisors from 13F filings

Historical chart of LGT Financial Advisors investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by LGT Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by LGT Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $376 50 7.52

More positions owned by LGT Financial Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Eafe Value Etf (EFV)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Total Usd (IUSB)
Apple (AAPL)
Ishares Tr S&p 100 Etf (OEF)
Chevron Corporation (CVX)
Vanguard Index Fds Total Stk Mkt (VTI)
Exxon Mobil Corporation (XOM)
Ishares Tr Russell 3000 Etf (IWV)

View all positions for LGT Financial Advisors

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Deep Track Capital
Morgan Stanley
Vivo Capital
Commodore Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Candriam Luxembourg S.C.A.
Acorn Capital Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Terns Pharmaceuticals